CollPlant Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Jun 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 4, 2027The maintenance fee for Methods of generating and using procollagen (US 9,095,569) comes due Feb 4, 2027. Unpaid by Aug 4, 2027, it lapses early.
- 1 fee due Mar 29, 2027The maintenance fee for Compositions Comprising Fibrous Polypeptides and Polysaccharides (US 9,145,463) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
- 1 fee due Apr 30, 2027The maintenance fee for Dermal Fillers and Applications Thereof (US 11,801,329) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Compositions comprising collagen and PRP for tissue regeneration (US 10,493,134) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,455,717 | Collagen producing plants and methods of generating and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,783,816 | Collagen producing plants and methods of generating and using same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,906,651 | Compositions Comprising Fibrous Polypeptides and Polysaccharides In force · Medium confidence | In force | Medium confidence | |
| US 9,145,463 | Compositions Comprising Fibrous Polypeptides and Polysaccharides In force · Medium confidence | In force | Medium confidence | |
| US 8,431,158 | Compositions Comprising Fibrous Polypeptides and Polysaccharides In force · High confidence | In force | High confidence | |
| US 9,095,569 | Methods of generating and using procollagen In force · From the USPTO record | In force | From the USPTO record | |
| US 8,759,487 | Methods of processing recombinant procollagen In force · From the USPTO record | In force | From the USPTO record | |
| US 10,493,134 | Compositions comprising collagen and PRP for tissue regeneration In force · From the USPTO record | In force | From the USPTO record | |
| US 10,799,616 | Cross-Linked Resilin-Containing Materials In force · High confidence | In force | High confidence | |
| US 10,716,876 | Method of generating collagen fibers In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 1 patent in force now held by others · 2 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 5 no status recorded